LYCA
Lycia Therapeutics, Inc. · Healthcare
Insiders bought $38.3M net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 30, 2026
Insider Buying
$38.3M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Oct 30, 2026
Venrock Healthcare Capital Partners III, L.P.
Lycia Therapeutics, Inc. (LYCA) has 3 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 30, 2026.
Inside the rolling window, 1 insider at Lycia Therapeutics, Inc. reported 6 open-market purchases totaling $38.3M and no open-market sales. The most active filer is 10% Owner Venrock Healthcare Capital Partners III, L.P. with 6 filings. Insiders have net bought $38.3M over the trailing 6 months. The largest single insider purchase in this window was $35.2M by 10% Owner Venrock Healthcare Capital Partners III, L.P. on Oct 26, 2026. The most recent open-market filing is a purchase of 15,000 shares by 10% Owner Venrock Healthcare Capital Partners III, L.P., dated Oct 28, 2026, worth $382K.
- Industry:Biotechnology
- CEO:Aetna Wun Trombley
- Employees:65
- HQ:South San Francisco, CA, US
- IPO:2026-10-23
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 15,000 | $382K | Oct 30 | — | SEC ↗ | |
| 10% Owner | Purchase | 1,000 | $26K | Oct 30 | — | SEC ↗ | |
| 10% Owner | Purchase | 9,004 | $237K | Oct 30 | — | SEC ↗ | |
Venrock Healthcare Capital Partners III, L.P.First in 7 months | 10% Owner | Purchase | 52,939 | $1.4M | Oct 27 | +1.1% | SEC ↗ |
Venrock Healthcare Capital Partners III, L.P.First in 7 months | 10% Owner | Purchase | 1,952,705 | $35.2M | Oct 27 | +1.1% | SEC ↗ |
Venrock Healthcare Capital Partners III, L.P.First in 7 months | 10% Owner | Purchase | 39,796 | $1.1M | Oct 27 | +1.1% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does LYCA have?
Lycia Therapeutics, Inc. (LYCA) has 3 SEC Form 4 filings (14 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 30, 2026.
When was the most recent SEC Form 4 filing for LYCA?
The most recent Form 4 filing for LYCA on Tracefour is dated Oct 30, 2026.
Who is the most active insider at LYCA?
The most active SEC Form 4 filer at LYCA in the rolling window is 10% Owner Venrock Healthcare Capital Partners III, L.P., with 6 filings.
What is the net insider flow at LYCA over the last 6 months?
Over the trailing 180 days, insiders at LYCA have net bought $38.3M based on SEC Form 4 disclosures.
What was the largest insider purchase at LYCA?
The largest single insider open-market purchase at LYCA in the rolling window was $35.2M by 10% Owner Venrock Healthcare Capital Partners III, L.P. on 2026-10-26.
What is the total insider buy and sell value at LYCA in the current window?
Inside the rolling window, insiders at LYCA bought $38.3M and sold $0 based on SEC Form 4 filings.
Can I get alerts for LYCA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Lycia Therapeutics, Inc. (LYCA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Lycia Therapeutics, Inc. is in the Healthcare sector.